The immunogenicity of the CAu.KEX1 during infections and the cross-reactivity of this protein with antibodies generated to the consensus protein NXT-2 provided the rationale for investigating NXT-2 as a vaccine candidate in an invasive C. auris infection model [32,33,37,38]. The gene discussed is NXT2; the disease is infection.